1. Wang, Ying, Ping, Li-Feng, Bai, Fu-Yan, Zhang, Xin-Huan, Li, Guang-Hong. . Hmgcs2 is the hub gene in diabetic cardiomyopathy and is negatively regulated by Hmgcs2, promoting high glucose-induced cardiomyocyte injury. In Immunity, inflammation and disease, 12, e1191. doi:10.1002/iid3.1191. https://pubmed.ncbi.nlm.nih.gov/38477658/
2. Tomita, Issei, Kume, Shinji, Sugahara, Sho, Araki, Shin-Ichi, Maegawa, Hiroshi. 2020. SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition. In Cell metabolism, 32, 404-419.e6. doi:10.1016/j.cmet.2020.06.020. https://pubmed.ncbi.nlm.nih.gov/32726607/
3. Cheng, Chia-Wei, Biton, Moshe, Haber, Adam L, Regev, Aviv, Yilmaz, Ömer H. . Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet. In Cell, 178, 1115-1131.e15. doi:10.1016/j.cell.2019.07.048. https://pubmed.ncbi.nlm.nih.gov/31442404/
4. Cai, Weijuan, Chong, Kunying, Huang, Yunfei, Huang, Chun, Yin, Liang. 2023. Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress. In Redox biology, 69, 103010. doi:10.1016/j.redox.2023.103010. https://pubmed.ncbi.nlm.nih.gov/38160540/
5. Martín-Adrados, Beatriz, Wculek, Stefanie K, Fernández-Bravo, Sergio, Blumberg, Richard S, Martínez-Naves, Eduardo. 2023. Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress. In Frontiers in immunology, 14, 1185517. doi:10.3389/fimmu.2023.1185517. https://pubmed.ncbi.nlm.nih.gov/37457727/
智鼠故事 
